Moody’s Upgrades Teva Pharmaceutical Industries Limited Rating to A3

January 14, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that Moody's Investor services has upgraded the Company's rating to A3 from Baa1. Following this most recent upgrade, the rating outlook is now stable.

Twitter
LinkedIn
Facebook
Email
Print

Asia